Updated Jul 16, 2026
Coastlands Capital LP has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $151K.
| Role | 10% Owner |
|---|
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | ADIL | ADIAL PHARMACEUTICALS, INC. | P — Open-market purchase | 1.7K | $2.70 | $5K |
| 2026-07-13 | ADIL | ADIAL PHARMACEUTICALS, INC. | P — Open-market purchase | 10.1K | $2.79 | $28K |
| 2026-07-01 | ADIL | ADIAL PHARMACEUTICALS, INC. | P — Open-market purchase | 25.0K | $2.60 | $65K |
| 2026-06-22 | KTTA | Pasithea Therapeutics Corp. | P — Open-market purchase | 100.0K | $0.53 | $53K |
| 2026-05-30 | ELOX | Eloxx Pharmaceuticals, Inc. | J — Other acquisition / disposition | 1.25M | $0.00 |
Coastlands Capital LP is a corporate insider — currently tracked as 10% Owner of ADIAL PHARMACEUTICALS, INC. (ADIL). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 4 open-market purchases ($151K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Coastlands Capital LP profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.